Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 11Neoplasm Metastasis 7Neoplasms 5Carcinoma, Renal Cell 3Tuberous Sclerosis 2Triple Negative Breast Neoplasms 2Recurrence 2Prostatic Neoplasms 2Neuroendocrine Tumors 2Leukemia, Myeloid, Acute 2Gastrointestinal Neoplasms 2Cholangiocarcinoma 2Carcinoma, Neuroendocrine 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Sarcoma 1Renal Cell Cancer Metastatic 1Relapsed Pediatric Solid Tumor 1Ovarian Neoplasms 1Osteosarcoma 1Nasopharyngeal Carcinoma 1Metatropic dwarfism 1Melanoma 1Lymphoma 1Liver Neoplasms 1Liver Failure 1Liver Diseases 1Liver Cirrhosis 1Leukemia, Myelomonocytic, Acute 1

Interventions

Nivolumab 25pembrolizumab 20Ipilimumab 15toripalimab 12Temozolomide 11Biopsy 8Dacarbazine 7Cyclophosphamide 6Blood Specimen Collection 6trametinib 5fludarabine 5dabrafenib 5camrelizumab 5atezolizumab 5Gene Expression Profiling 5Chemotherapy, Adjuvant 5durvalumab 4binimetinib 4aldesleukin 4Interleukin-2 4Injections 4Carboplatin 4tislelizumab 3palbociclib 3encorafenib 3apatinib 3Sorafenib 3Paclitaxel 3Introns 3Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Melanoma × Everolimus × Clear all
NCT01960829 2015-05-01

Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study

Peking University Cancer Hospital & Institute

Phase 2 Unknown
60 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡